LUPIN

Lupin is a pharmaceutical company headquartered in Mumbai with a strong presence in India and a significant role in the global generics market. It operates as an innovation-led transnational firm, developing and commercializing a diverse range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company focuses on several therapeutic areas, including cardiovascular, diabetology, asthma, pediatric, gastrointestinal, anti-infective, and non-steroidal anti-inflammatory drugs (NSAIDs). Lupin serves multiple geographies such as the United States, India, South Africa, Asia Pacific, Latin America, Europe, the Middle East, and other emerging economies.